<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Intensive Care Med Exp</journal-id><journal-id journal-id-type="iso-abbrev">Intensive Care Med Exp</journal-id><journal-title-group><journal-title>Intensive Care Medicine Experimental</journal-title></journal-title-group><issn pub-type="epub">2197-425X</issn><publisher><publisher-name>Springer International Publishing</publisher-name><publisher-loc>Cham</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27682607</article-id><article-id pub-id-type="pmc">5040657</article-id><article-id pub-id-type="publisher-id">105</article-id><article-id pub-id-type="doi">10.1186/s40635-016-0105-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Plasmadiafiltration ameliorating gut mucosal barrier dysfunction and improving survival in porcine sepsis models</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Ming Xin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Liu</surname><given-names>Jun Feng</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Jian Da</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kuang</surname><given-names>Ding Wei</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Xiang</surname><given-names>Jian Bing</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sun</surname><given-names>Peng</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Xue</surname><given-names>Jun</given-names></name><address><phone>86-21-52887797</phone><email>xuejun@fudan.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gu</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hao</surname><given-names>Chuan Ming</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>Department of Nephrology, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai, 200040 China </aff><aff id="Aff2"><label>2</label>Department of General Surgery, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai, 200040 China </aff><aff id="Aff3"><label>3</label>Department of Critical Care Medicine, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai, 200040 China </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>9</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>12</month><year>2016</year></pub-date><volume>4</volume><elocation-id>31</elocation-id><history><date date-type="received"><day>21</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>9</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p>The object of this study is to explore whether the plasmadiafiltration (PDF) is more effective in improving the intestinal mucosal barrier function by removing more key large molecular inflammatory mediators and then prolonging the survival time.</p></sec><sec><title>Methods</title><p>Totally, 24 porcine sepsis models induced by cecal ligation and puncture (CLP) operation were randomly divided into three groups: PDF group, high-volume hemofiltration (HVHF) group, and control group, and received 8&#x000a0;h treatment, respectively. The expression of ZO-1 and occludin in intestinal mucosal epithelial cells were detected by immunohistochemistry, and apoptotic protein caspase-3-positive lymphocytes were signed in mesenteric lymph nodes by TUNEL staining. The hemodynamic parameters were measured by invasive cavity detection. The tumor necrosis factor alpha (TNF&#x003b1;) and high-mobility group protein 1 (HMGB1) were tested by ELISA method. And then, the survival curves with all-cause death were compared with three groups.</p></sec><sec><title>Results</title><p>PDF led to a superior reversal of sepsis-related hemodynamic impairment and serum biochemistry abnormalities and resulted in longer survival time compared with HVHF and control (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01). Definitive protection from excessive TNF-&#x003b1; and HMGB1 response were only achieved by PDF. A more regular distribution pattern of ZO-1 and occludin along the epithelium was found in PDF animals (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01). The presence of apoptotic lymphocytes was significantly reduced in the PDF animals (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01).</p></sec><sec><title>Conclusions</title><p>PDF can effectively eliminate more pivotal inflammatory mediators of TNF&#x003b1; and HMGB1 and reduce the inflammation damage of the intestinal mucosal barrier and apoptosis of lymphocyte then improve the circulation function and prolong the survival time.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Cecal ligation perforation (CLP)</kwd><kwd>Sepsis</kwd><kwd>Plasmadiafiltration</kwd><kwd>Inflammatory mediators</kwd><kwd>Intestinal mucosal barrier</kwd></kwd-group><funding-group><award-group><funding-source><institution>National Nature Science Foundation of China</institution></funding-source><award-id>30770541;81271731</award-id><principal-award-recipient><name><surname>Xue</surname><given-names>Jun</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p>During sepsis, the most frequent complication within the gastrointestinal tract is mucosal barrier dysfunction. Gut barrier lesion plays an important role in the pathophysiology of sepsis by promoting bacterial translocation [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], which leads to secondary infection and multiple organ failure. The intestinal mucosal barrier consists of mechanical and immunological barrier. Unfortunately, the cascade of inflammation directly injuries intestinal epithelial tight junction permeability [<xref ref-type="bibr" rid="CR3">3</xref>], particularly for tumor necrosis factor alpha (TNF&#x003b1;) and high-mobility group protein 1 (HMGB1) [<xref ref-type="bibr" rid="CR4">4</xref>], by impairing the function of mitochondria [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. And meanwhile cytokine storm uptakes apoptosis of lymphocytes and intestinal epithelium cells via caspase active [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Accordingly, epithelial dysfunction may be a common final pathway contributing to organ dysfunction in sepsis and other forms of critical illness. It plays a key role in the prognosis of sepsis and it should become the focus of the sepsis treatment.</p><p>The overall therapies and concept of blood purification have evolved toward non-specifically removing a broad spectrum of plasma inflammatory mediators and also attenuating the tissue overwhelming systemic expression of pro- and anti-inflammatory mediators [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Rebuilding of immune homeostasis is thought to be able to improve outcomes and survival. Plasmadiafiltration (PDF), which used high cut-off hemofilter and diluted plasma as replacement fluid, represents new logical strategy to significantly increase middle- and high-molecule-weight mediator removal with low substitution flow rate. Compared to coupled plasma filtration and absorption or other plasmapheresis, PDF possesses better restoration of homeostasis and similar efficient cytokine clearance with simpler therapeutic modality. And meanwhile, a little fresh iced plasma complement essential coagulation factors and immunoglobulin that benefits sepsis recovery.</p><p>Our previous in vitro study [<xref ref-type="bibr" rid="CR11">11</xref>] had demonstrated the safety and effectiveness of PDF for removing a sufficiently wide of inflammatory mediators and small molecular toxins from circulation, and it provided acceptable albumin depletion by a little plasma supplement.</p><p>This in vivo study was to explore whether PDF was more effective improving the intestinal mucosal barrier function by removing more key large molecular inflammatory mediators and then prolonging the survival time than that of classical hemofiltration.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Anesthesia and surgical preparation</title><p>The Animal Care Committee of the Fudan University approved the study. Twenty-four clean grade minipigs (body weight [BW] 36&#x02009;&#x000b1;&#x02009;1.3&#x000a0;kg, aged 80&#x02009;&#x000b1;&#x02009;1.2&#x000a0;days) were premedicated intramuscularly with ketamine (10&#x02013;15&#x000a0;mg/kg) and diazepam 10&#x000a0;mg. Anesthesia ventilator (Matrx Model3000, USA) maintained with inhalation of mixture 1&#x02013;5&#x000a0;% isoflurane and oxygen by an endotracheal intubation. A catheter was inserted in the left carotid artery for blood pressure monitoring and blood sampling. Two 7 French Swan-Ganz flow-directed pacing catheters (131F7, 1.5&#x000a0;ml CAP, Edwards, USA) were introduced aseptically via two 8 Fr. introducers (Exacta Percutaneous Sheath Inducer) into the right proximal and distal jugular veins, under continuous pressure monitoring, their tips were advanced into the pulmonary artery and right atrium, respectively. During anesthesia, the animals received continuous infusions with isotonic sodium chloride at 5&#x000a0;ml/kg/h. Baseline data were collected.</p></sec><sec id="Sec4"><title>CLP models</title><p>CLP operation was performed with laparoscopic surgery (Olympus, Japan). Four incisions of 0.5&#x02013;1.0&#x000a0;cm were made on the insufflated abdomen with carbon dioxide gas and trocars were placed through these incisions, then laparoscope and other instruments were introduced into the abdomen through these trocars. The cecum was identified and exposed and a specified 6&#x000a0;cm of the distal end of the cecum was ligated. Next, one incision of 1&#x000a0;cm at the free end of the cecum was made. The cecum was then gently compressed to extrude amount of cecal content. At last the instruments were pulled out and the abdominal skin incisions were closed. After resuscitation the porcines of CLP were backed animal room with free diet.</p></sec><sec id="Sec5"><title>Experiment protocol</title><p>After 24&#x000a0;h of CLP operation, the experimental animals were induced with forward mentioned inhalation anesthesia and allocated into PDF, high-volume hemofiltration (HVHF) and control group in accordance with random digital generated by Stata 10.0 software (Stata Co. Ltd, USA). And the animals were then recannulated to begin the experimental period. The control group treated with hemoperfusion through an empty column with the same blood flow rate and anticoagulation method as that of the PDF and HVHF. All the animals received a continuous infusion of isotonic sodium chloride. The infusion rate was adjusted according to the clinical situation and to reach target central venous pressure of 5&#x02013;10&#x000a0;cmH<sub>2</sub>O. After a maximal therapeutic and observation period of 32&#x000a0;h, animals were lethally injected with potassium chloride.</p></sec><sec id="Sec6"><title>Plasmadiafiltration</title><p>PDF therapies were delivered by the KM8900 machine (Quarary, Japan), and the EVAL membrane hollow fiber dialyzers were used, which had high cut-off of 60&#x02013;70&#x000a0;KD (Evacure EC-2A, inside diameter 175&#x000a0;&#x003bc;m, wall thickness 40&#x000a0;&#x003bc;m, and effective surface area 1.0&#x000a0;m<sup>2</sup>, Sichuan Chemical Industry, Japan). Blood flow rate was set as 2.5&#x000a0;ml/kg/min throughout the whole experiment while the replacing fluid that was consisted of commercially available substitution and plasma at the ratio of 3:1 was infused in a post-dilution mode at the desired rate of 4&#x000a0;ml/kg/h to maintain a zero fluid balance. Dialysate flow rate was set at 1000&#x000a0;ml/h consistently and net ultra filtration rate adjusted according to central venous pressure. For anticoagulation, porcines were given a loading dose of 6250&#x000a0;U heparin, followed by a continuous infusion of 625&#x000a0;U/h.</p></sec><sec id="Sec7"><title>High volume hemofiltration</title><p>Zero-balanced hemofiltration was performed in a predilution mode with rate of 60&#x000a0;ml/kg/h using a polysulfone membrane (F60 HPS, an area of 1.3&#x000a0;m<sup>2</sup>, Fresenius, Germany) connected to a Diapact machine (B.Braun, Germany). Blood flow rate and anticoagulation method were designed as same as PDF treatment.</p></sec><sec id="Sec8"><title>Vital signs assessment, biochemistry data, and cytokine measurement</title><p>Internal temperature, heart rate, respiratory rate, arterial blood pressure, blood oxygen saturation, cardiac output, pulmonary arterial wedge pressure, and central venous pressure were observed by multichannel physiological monitor (Agilent<sup>&#x000ae;</sup>, Polymount GCX Corporation, USA) with different transducer connected to left carotid artery catheter and right jugular venous Swan-Ganz catheter respectively at 0, 24&#x000a0;h, and then every 15&#x000a0;min after treatment. And urine volume per hour was documented with catheterization.</p><p>Furthermore, blood sample were obtained for determination of leucocyte counts, serum sugar, creatinine, lactate, and blood gases at points 0 and 24&#x000a0;h and then every 2&#x000a0;h after treatment with COULTER LH750 (Beckman Coulter, USA) and ISTAT&#x000ae; Handheld (Abbott Point of Care, USA).</p><p>Serum samples were gathered at the same time point and stored in &#x02212;70&#x000a0;&#x000b0;C for later cytokines assay. The concentrations of HMGB1 and TNF-&#x003b1; trimer were detected by specific enzyme-linked immunosorbent assay (ELISA) kits, following the protocols of the manufacture (R&#x00026;D Systems Co., Minneapolis, MN).</p></sec><sec id="Sec9"><title>Immunohistochemistry of ZO-1 and occludin</title><p>Immediately after death of CLP porcine, the 5&#x000a0;cm ileum section was obtained, and randomly sampled tissue blocks of approximately 50&#x02009;&#x000d7;&#x02009;50&#x02009;&#x000d7;&#x02009;50&#x000a0;&#x003bc;m were fixed over night in 10&#x000a0;% (wt/vol) PBS-buffered formaldehyde, following the protocols of the former paper described [<xref ref-type="bibr" rid="CR12">12</xref>]. The positive areas were captured by Nikon System (Nikon NIS-Elements, Nikon Eclipse 50i H550S, DS-FiI, Nikon, Japan) and then immunochemistry index referred to the ratio of mean optical density/area was calculated with photo analysis software Image pro&#x000ae; plus 6.0 (Media Cybernetics, USA). And all immunohistology data were quantitatively analyzed by Shanghai Showbio Biotechnology Company, as a blinded independent third-party testing agency.</p></sec><sec id="Sec10"><title>TUNEL assay for caspase-3-positive lymphocytes</title><p>Mesenteric lymph nodes were obtained pre-CLP and at the moment of death, respectively, and were fixed as forward mentioned method. The terminal deoxynucleotidyl transferase mediated dUTP-biotin nick end labeling (TUNEL) assay was used to observe apoptotic lymphocytes in the mesenteric lymph node, following the protocols of the former paper described [<xref ref-type="bibr" rid="CR12">12</xref>]. Brownish-yellow stained lymphocytes were an indication of positive cells. The apoptotic lymphocytes were identified and counted.</p></sec><sec id="Sec11"><title>Statistical methods</title><p>All numerical data were expressed as mean&#x02009;&#x000b1;&#x02009;standard error. Normal distributed data with homogeneity or heterogeneity of variance was compared with Student&#x02019;s <italic>t</italic> tests or Welch&#x02019;s <italic>t</italic> test. And skewed distribution data was used Wilcoxon rank test. Multiple linear regressions were used to determine an association between cytokines and hemodynamic parameters. Survival times were calculated by Kaplan-Meier analysis and compared by the log-rank test. All analyses were performed by Stata software package 10.0 (StataCorp LP, College Station, TX, USA). A <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered to be of significant difference.</p></sec></sec><sec id="Sec12"><title>Results</title><sec id="Sec13"><title>Clinic data and laboratory parameters</title><p>All animals possessed the similar physiological attributes at baseline or after 24&#x000a0;h CLP operation between three groups (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). And meanwhile, all CLP porcines conformed to sepsis shock diagnostic standard after 24&#x000a0;h, according to the updated sepsis 3.0 criteria [<xref ref-type="bibr" rid="CR13">13</xref>], the occurrence of sepsis shock was assumed SOFA score &#x02265;2 (sequential organ function assessment (SOFA)) associated with at least two of the following signs: systolic blood pressure &#x02264;100&#x000a0;mmHg and serum lactate &#x02265;2&#x000a0;mmol/l.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Comparison of hemodynamics and blood variables in three groups</p></caption><table frame="hsides" rules="groups"><thead><tr valign="top"><th>Variable</th><th>Group</th><th>Time (hour)</th><th/><th/><th/><th/><th/></tr><tr valign="top"><th/><th/><th>Baseline</th><th>24</th><th>26</th><th>28</th><th>30</th><th>32</th></tr></thead><tbody><tr valign="top"><td rowspan="3">PaO<sup>2</sup> (mmHg)</td><td>PDF</td><td>108.9&#x02009;&#x000b1;&#x02009;20.1</td><td>66.5&#x02009;&#x000b1;&#x02009;18.5a<sup>a</sup>
</td><td>74.50&#x02009;&#x000b1;&#x02009;5.79<sup>b</sup>
</td><td>84.67&#x02009;&#x000b1;&#x02009;6.95<sup>b</sup>
</td><td>93.00&#x02009;&#x000b1;&#x02009;5.18</td><td>101.0&#x02009;&#x000b1;&#x02009;5.33</td></tr><tr valign="top"><td>HVHF</td><td>106.9&#x02009;&#x000b1;&#x02009;23.1</td><td>65.8&#x02009;&#x000b1;&#x02009;19.8a<sup>a</sup>
</td><td>68.83&#x02009;&#x000b1;&#x02009;3.19</td><td>74.17&#x02009;&#x000b1;&#x02009;3.26</td><td>81.83&#x02009;&#x000b1;&#x02009;1.94</td><td>89.50&#x02009;&#x000b1;&#x02009;4.76</td></tr><tr valign="top"><td>Con.</td><td>110.2&#x02009;&#x000b1;&#x02009;21.9</td><td>68.0&#x02009;&#x000b1;&#x02009;16.9a<sup>a</sup>
</td><td>58.50&#x02009;&#x000b1;&#x02009;2.43</td><td>54.67&#x02009;&#x000b1;&#x02009;2.73</td><td>51.00&#x02009;&#x000b1;&#x02009;2.00</td><td/></tr><tr valign="top"><td>MAP</td><td>PDF</td><td>77.7&#x02009;&#x000b1;&#x02009;2.07</td><td>54.50&#x02009;&#x000b1;&#x02009;1.87<sup>a</sup>
</td><td>56.33&#x02009;&#x000b1;&#x02009;1.63</td><td>58.33&#x02009;&#x000b1;&#x02009;1.63 <sup>b</sup>
</td><td>60.50&#x02009;&#x000b1;&#x02009;1.87</td><td>62.50&#x02009;&#x000b1;&#x02009;1.87</td></tr><tr valign="top"><td/><td>HVHF</td><td>79.2&#x02009;&#x000b1;&#x02009;1.93</td><td>52.83&#x02009;&#x000b1;&#x02009;1.72<sup>a</sup>
</td><td>51.83&#x02009;&#x000b1;&#x02009;1.33</td><td>50.33&#x02009;&#x000b1;&#x02009;0.82</td><td>50.67&#x02009;&#x000b1;&#x02009;1.75</td><td>52.53&#x02009;&#x000b1;&#x02009;1.87</td></tr><tr valign="top"><td/><td>Con.</td><td>76.9&#x02009;&#x000b1;&#x02009;1.89</td><td>52.50&#x02009;&#x000b1;&#x02009;1.87<sup>a</sup>
</td><td>50.00&#x02009;&#x000b1;&#x02009;2.00</td><td>47.33&#x02009;&#x000b1;&#x02009;2.25</td><td>44.83&#x02009;&#x000b1;&#x02009;1.84</td><td/></tr><tr valign="top"><td>PAWP</td><td>PDF</td><td>11.35&#x02009;&#x000b1;&#x02009;2.85</td><td>22.00&#x02009;&#x000b1;&#x02009;3.74<sup>a</sup>
</td><td>19.67&#x02009;&#x000b1;&#x02009;2.58</td><td>17.67&#x02009;&#x000b1;&#x02009;1.97<sup>b</sup>
</td><td>16.17&#x02009;&#x000b1;&#x02009;1.47</td><td>14.00&#x02009;&#x000b1;&#x02009;1.79</td></tr><tr valign="top"><td/><td>HVHF</td><td>11.48&#x02009;&#x000b1;&#x02009;2.32</td><td>23.00&#x02009;&#x000b1;&#x02009;3.74<sup>a</sup>
</td><td>22.33&#x02009;&#x000b1;&#x02009;3.27</td><td>21.33&#x02009;&#x000b1;&#x02009;3.20</td><td>20.50&#x02009;&#x000b1;&#x02009;3.08</td><td>20.17&#x02009;&#x000b1;&#x02009;3.43</td></tr><tr valign="top"><td/><td>Con.</td><td>12.01&#x02009;&#x000b1;&#x02009;3.07</td><td>20.50&#x02009;&#x000b1;&#x02009;1.87<sup>a</sup>
</td><td>22.33&#x02009;&#x000b1;&#x02009;3.01</td><td>24.00&#x02009;&#x000b1;&#x02009;3.63</td><td>25.83&#x02009;&#x000b1;&#x02009;3.76</td><td/></tr><tr valign="top"><td>CO</td><td>PDF</td><td>2.29&#x02009;&#x000b1;&#x02009;0.56</td><td>2.12&#x02009;&#x000b1;&#x02009;0.25<sup>a</sup>
</td><td>2.10&#x02009;&#x000b1;&#x02009;0.26</td><td>2.10&#x02009;&#x000b1;&#x02009;0.28 <sup>b</sup>
</td><td>2.18&#x02009;&#x000b1;&#x02009;0.27</td><td>2.19&#x02009;&#x000b1;&#x02009;0.26</td></tr><tr valign="top"><td/><td>HVHF</td><td>2.33&#x02009;&#x000b1;&#x02009;0.74</td><td>2.19&#x02009;&#x000b1;&#x02009;0.27<sup>a</sup>
</td><td>2.09&#x02009;&#x000b1;&#x02009;0.24</td><td>1.98&#x02009;&#x000b1;&#x02009;0.22</td><td>1.82&#x02009;&#x000b1;&#x02009;0.16</td><td>1.71&#x02009;&#x000b1;&#x02009;0.17</td></tr><tr valign="top"><td/><td>Con.</td><td>2.31&#x02009;&#x000b1;&#x02009;0.42</td><td>2.18&#x02009;&#x000b1;&#x02009;0.28<sup>a</sup>
</td><td>1.83&#x02009;&#x000b1;&#x02009;0.28</td><td>1.53&#x02009;&#x000b1;&#x02009;0.15</td><td>1.29&#x02009;&#x000b1;&#x02009;0.10</td><td/></tr><tr valign="top"><td>Urine flow (ml/h)</td><td>PDF</td><td>95.4&#x02009;&#x000b1;&#x02009;0.87</td><td>18.33&#x02009;&#x000b1;&#x02009;1.63<sup>a</sup>
</td><td>20.00&#x02009;&#x000b1;&#x02009;1.41</td><td>23.00&#x02009;&#x000b1;&#x02009;2.19 <sup>b</sup>
</td><td>26.17&#x02009;&#x000b1;&#x02009;2.40</td><td>29.33&#x02009;&#x000b1;&#x02009;2.34</td></tr><tr valign="top"><td/><td>HVHF</td><td>97.6&#x02009;&#x000b1;&#x02009;0.90</td><td>20.00&#x02009;&#x000b1;&#x02009;2.61<sup>a</sup>
</td><td>19.33&#x02009;&#x000b1;&#x02009;2.16</td><td>18.67&#x02009;&#x000b1;&#x02009;2.42</td><td>18.00&#x02009;&#x000b1;&#x02009;2.28</td><td>17.50&#x02009;&#x000b1;&#x02009;2.88</td></tr><tr valign="top"><td/><td>Con.</td><td>96.5&#x02009;&#x000b1;&#x02009;0.73</td><td>20.67&#x02009;&#x000b1;&#x02009;2.42<sup>a</sup>
</td><td>15.67&#x02009;&#x000b1;&#x02009;3.78</td><td>10.33&#x02009;&#x000b1;&#x02009;3.89</td><td>6.17&#x02009;&#x000b1;&#x02009;4.54</td><td/></tr><tr valign="top"><td>WBC (&#x02009;&#x000d7;&#x02009;10<sup>9</sup>/L)</td><td>PDF</td><td>13.8&#x02009;&#x000b1;&#x02009;4.3</td><td>26.8&#x02009;&#x000b1;&#x02009;5.3a<sup>a</sup>
</td><td>25.8&#x02009;&#x000b1;&#x02009;4.9</td><td>23.6&#x02009;&#x000b1;&#x02009;5.1</td><td>22.7&#x02009;&#x000b1;&#x02009;4.5</td><td>20.8&#x02009;&#x000b1;&#x02009;5.5</td></tr><tr valign="top"><td/><td>HVHF</td><td>12.9&#x02009;&#x000b1;&#x02009;5.6</td><td>27.7&#x02009;&#x000b1;&#x02009;5.9a<sup>a</sup>
</td><td>26.2&#x02009;&#x000b1;&#x02009;6.1</td><td>24.5&#x02009;&#x000b1;&#x02009;3.9</td><td>23.2&#x02009;&#x000b1;&#x02009;6.8</td><td>21.9&#x02009;&#x000b1;&#x02009;7.5</td></tr><tr valign="top"><td/><td>Con.</td><td>15.1&#x02009;&#x000b1;&#x02009;6.2</td><td>23.4&#x02009;&#x000b1;&#x02009;4.2a<sup>a</sup>
</td><td>25.8&#x02009;&#x000b1;&#x02009;7.3</td><td>24.4&#x02009;&#x000b1;&#x02009;4.2</td><td>26.3&#x02009;&#x000b1;&#x02009;4.4</td><td/></tr><tr valign="top"><td>Scr (&#x003bc;mol /l)</td><td>PDF</td><td>83.5&#x02009;&#x000b1;&#x02009;15.3</td><td>143.1&#x02009;&#x000b1;&#x02009;76.4<sup>a</sup>
</td><td>131.2&#x02009;&#x000b1;&#x02009;56.3</td><td>127.4&#x02009;&#x000b1;&#x02009;26.8</td><td>109.7&#x02009;&#x000b1;&#x02009;21.4</td><td>97.62&#x02009;&#x000b1;&#x02009;23.5</td></tr><tr valign="top"><td/><td>HVHF</td><td>85.8&#x02009;&#x000b1;&#x02009;12.5</td><td>134.7&#x02009;&#x000b1;&#x02009;86.3<sup>a</sup>
</td><td>149.5&#x02009;&#x000b1;&#x02009;66.7</td><td>142.3&#x02009;&#x000b1;&#x02009;45.2</td><td>138.3&#x02009;&#x000b1;&#x02009;33.4</td><td>120.5&#x02009;&#x000b1;&#x02009;32.8</td></tr><tr valign="top"><td/><td>Con.</td><td>81.5&#x02009;&#x000b1;&#x02009;10.9</td><td>140.3&#x02009;&#x000b1;&#x02009;80.4<sup>a</sup>
</td><td>155.9&#x02009;&#x000b1;&#x02009;67.3</td><td>178.2&#x02009;&#x000b1;&#x02009;55.4</td><td>195.8&#x02009;&#x000b1;&#x02009;32.1</td><td/></tr><tr valign="top"><td>LAC (mmol/l)</td><td>PDF</td><td>1.47&#x02009;&#x000b1;&#x02009;0.42</td><td>4.28&#x02009;&#x000b1;&#x02009;1.40<sup>a</sup>
</td><td>3.26&#x02009;&#x000b1;&#x02009;1.12</td><td>2.21&#x02009;&#x000b1;&#x02009;1.08<sup>b</sup>
</td><td>1.97&#x02009;&#x000b1;&#x02009;0.76</td><td>1.74&#x02009;&#x000b1;&#x02009;0.45</td></tr><tr valign="top"><td/><td>HVHF</td><td>1.58&#x02009;&#x000b1;&#x02009;0.35</td><td>4.32&#x02009;&#x000b1;&#x02009;1.18<sup>a</sup>
</td><td>3.47&#x02009;&#x000b1;&#x02009;1.16</td><td>3.01&#x02009;&#x000b1;&#x02009;0.97</td><td>2.14&#x02009;&#x000b1;&#x02009;0.65</td><td>1.88&#x02009;&#x000b1;&#x02009;0.56</td></tr><tr valign="top"><td/><td>Con.</td><td>1.35&#x02009;&#x000b1;&#x02009;0.52</td><td>3.94&#x02009;&#x000b1;&#x02009;1.32<sup>a</sup>
</td><td>4.97&#x02009;&#x000b1;&#x02009;1.54</td><td>5.87&#x02009;&#x000b1;&#x02009;1.17</td><td>7.45&#x02009;&#x000b1;&#x02009;0.49</td><td/></tr><tr valign="top"><td>Survival rate</td><td>PDF</td><td>8/8</td><td>8/8</td><td>8/8</td><td>8/8</td><td>7/8</td><td>4/8</td></tr><tr valign="top"><td/><td>HVHF</td><td>8/8</td><td>8/8</td><td>6/8</td><td>4/8</td><td>2/8</td><td>2/8</td></tr><tr valign="top"><td/><td>Con.</td><td>8/8</td><td>8/8</td><td>3/8</td><td>2/8</td><td>2/8</td><td>0/8</td></tr></tbody></table><table-wrap-foot><p>
<italic>PDF</italic> plasmadiafiltration, <italic>HVHF</italic> high-volume hemofiltration, <italic>Con</italic>. control, <italic>PaO</italic>
<sup><italic>2</italic></sup> partial pressure of blood oxygen, <italic>MAP</italic> mean arterial pressure, <italic>PAWP</italic> pulmonary artery wedge pressure, <italic>CO</italic> cardiac output, <italic>WBC</italic> white blood cell, <italic>Scr</italic> serum creatinine, <italic>LAC</italic> lactate</p><p>
<sup>a</sup>
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. the respective value at baseline</p><p>
<sup>b</sup>
<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. the HVHF or control</p></table-wrap-foot></table-wrap></p><p>After the onset of sepsis shock animals exhibited macrocirculatory derangement characterized by decreases in mean arterial pressure (MAP) and cardiac output (CO), and pulmonary disorders indicated by increase in pulmonary artery wedge pressure (PAWP) and decrease in partial pressure of blood oxygen (PaO<sub>2</sub>), (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). PDF led to a distinctly superior reversal of sepsis-related hemodynamic impairment compared with HVHF and control. And meanwhile, the values of serum lactate, creatinine, and leucocyte were elevated after 24&#x000a0;h postinduction of CLP in all groups and much more normalized during the course of disease in PDF than in HVHF and control, only except leucocyte. This resulted in a definitive prevention of sepsis shock by PDF in a total of four porcines, two of which belonged to HVHF and no animals from control survived (see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Effects of extracorporeal blood purification on survival of cecal ligation puncture (CLP) porcine. Survival time (hours) was observed from the start of CLP. <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, PDF vs. HVHF or control group, respectively</p></caption><graphic xlink:href="40635_2016_105_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec14"><title>Changes of cytokines</title><p>Differences in these circulating plasma cytokine concentrations for septic shock porcines therapy with PDF, HVHF, or control were shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. Baseline or values of 24&#x000a0;h after CLP were not different among the three groups for any cytokine. However, CLP resulted in an increase of TNF-&#x003b1; and HMGB1 level. PDF more efficiently attenuated the TNF-&#x003b1; and HMGB1 level in serum (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). And meanwhile, by multiple linear regressions analysis, only serum TNF-&#x003b1; level was significantly negative associated with MAP and CO, respectively (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).<fig id="Fig2"><label>Fig. 2</label><caption><p>Plasma tumor necrosis factor (TNF-&#x003b1;) (<bold>a</bold>) and high mobility group protein 1 (HMGB1) (<bold>b</bold>) levels obtained at different points of time. Definitive protection from overwhelming TNF-&#x003b1; and HMGB1 response were only achieved by plasmadiafiltration (PDF). Attenuation of cytokines was most effective in animals undergoing PDF. (<italic>a</italic>) <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. 0&#x000a0;h; (<italic>b</italic>) <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. HVHF or control, respectively</p></caption><graphic xlink:href="40635_2016_105_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec15"><title>Effects of sepsis on gut tight conjunction</title><p>ZO-1 and occludin were measured by immunohistochemistry in ileum sections. Results indicate that, in the ileum tissues collected from CLP porcines, ZO-1 and occludin were comparatively continuously distributed along the epithelium in PDF group. In contrast, a significant disruption of immunosignal for them was observed along the epithelium in HVHF and control group, particularly for control animals, almost all-normal construction disappeared and infiltrated with a lot of inflammatory cells. (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a, b)<fig id="Fig3"><label>Fig. 3</label><caption><p>Immunohistochemical localization of zonula occludens (ZO)-1 (<bold>b</bold>) and occludin (<bold>a</bold>) in the ileum tissue from cecal ligation puncture (CLP) porcines. A more regular distribution pattern of ZO-1 and occludin (see <italic>arrow</italic>) along the epithelium was found in PDF animals. Contrastingly, a significant disruption of immunosignal for them was observed along the epithelium in HVHF (see <italic>arrow</italic>) and control group, particularly for control animals; almost all-normal construction disappeared and infiltrated with a lot of inflammatory cells. <italic>p</italic>&#x02009;&#x0003c;&#x02009;0. 01 PDF group vs. HVHF group, or control group, respectively. <italic>IOD</italic> immunochemistry optical density</p></caption><graphic xlink:href="40635_2016_105_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec16"><title>Numbers of apoptotic lymphocytes in the mesenteric lymph nodes</title><p>Almost no apoptotic lymphocyte cells were detected in mesenteric lymph nodes at baseline (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). At the endpoint of CLP induced sepsis shock, mesenteric lymph nodes from CLP animals demonstrated a marked appearance of dark brown apoptotic cells and intercellular apoptotic fragments (see arrow in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). The presence of apoptotic cells or fragments was significantly reduced in the PDF animals (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Effects of cecal ligation puncture (CLP) induced sepsis on apoptosis of lymphocytes. Almost no apoptotic cells were detected in mesenteric lymph nodes at baseline. At the endpoint of CLP induced sepsis shock, mesenteric lymph nodes from CLP animals demonstrated a marked appearance of <italic>dark brown</italic> apoptotic cells and intercellular apoptotic fragments (see <italic>arrow</italic>). The presence of apoptotic cells or fragments was significantly reduced in the PDF animals. (<italic>a</italic>) <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 vs. baseline; (<italic>b</italic>) <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01</p></caption><graphic xlink:href="40635_2016_105_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec17"><title>Discussion</title><p>Polymicrobial sepsis induced by cecal ligation and puncture (CLP) is the most frequently used model because it closely mimics the progression and attributes of human sepsis [<xref ref-type="bibr" rid="CR14">14</xref>]. In addition, the higher the ligation and the bigger the incision size, the higher the mortality. Actually, most of sepsis-induced patients usually suffer from multiple organs dysfunction and sepsis shock in the clinic practice. Here, CLP with higher ligation and bigger incision successfully induced serious illness model that was full compliance with sepsis shock diagnostic standard after 24&#x000a0;h, according to the updated sepsis 3.0 criteria [<xref ref-type="bibr" rid="CR13">13</xref>], and which completely recreated human sepsis progression with similar hemodynamic and metabolic phases and the presence of both hyper- and hypoinflammatory phases, and also with prolonged and lower elevation of cytokine release, as in humans.</p><p>Recent technological progress has increased the number of techniques available for blood purification and their performance [<xref ref-type="bibr" rid="CR15">15</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>]. Unfortunately, recent a series of large multiple centers randomized controlled trials demonstrate that neither the different technique [<xref ref-type="bibr" rid="CR18">18</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref>] nor the treatment dosage [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>] had an impact on patient survival. Otherwise, PDF, the newer hybrid technique, which combines the hemodynamic and homeostasis stability of continuous renal replacement therapy with a more efficient depletion of broad spectrum of plasma inflammatory mediators and toxins similar to plasmapheresis, has been introduced as a new cost-effective simple approach to the treatment of acute kidney injury (AKI) in the sepsis shock. Our previous in vitro study [<xref ref-type="bibr" rid="CR11">11</xref>] had demonstrated the safety and effectiveness of PDF for removing a sufficiently wide of inflammatory mediators and hypercatabolic toxins from circulation, and it provided acceptable albumin depletion by a little fresh iced plasma supplement that also benefited recovery of coagulation and immunity.</p><p>Delayed therapy was performed in this experiment protocol differentiated to previous animal research in order to preferably simulate the clinic practice. And the choice of 8&#x000a0;h treatment was supported from the results that daily hemodialysis or hemofiltration presented excellent detoxification with cardiovascular tolerability and similar outcomes [<xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>], and meanwhile ameliorated anticoagulant dosage and disturbance of antibiotic concentration compared with continuous blood purification [<xref ref-type="bibr" rid="CR28">28</xref>]. As expected result, PDF demonstrated significantly more effective prevention of sepsis-associated hemodynamic deterioration than HVHF and control. And meanwhile, the values of serum lactate, creatinine, and leucocyte were elevated after 24&#x000a0;h postinduction of CLP in all groups and much more normalized during the course of disease in PDF than in HVHF and control, only except leucocyte. This resulted in a definitive prevention of sepsis shock by PDF in a total of four porcines, two of which belonged to HVHF and no animals from control survived.</p><p>In our study, favorable clinical outcomes that were convincible elucidated that PDF with high cut-off (HCO) membrane was more efficient in regard to cytokine clearances, improved injury of gut tight junction and ameliorated apoptosis of lymphocytes. In animal models of sepsis, HCO membranes improve hemodynamics and prolong survival [<xref ref-type="bibr" rid="CR29">29</xref>]. In patients with sepsis-related acute kidney injury, Morgera and colleagues [<xref ref-type="bibr" rid="CR30">30</xref>] reported a significant higher clearance of cytokines and a reduction in vasopressor requirements with the use of HCO hemofiltration. In another randomized research, HCO hemofiltration restored the monocyte proliferation capacity of septic patients, probably by eliminating immunomodulatory mediators [<xref ref-type="bibr" rid="CR31">31</xref>]. As is known, connective removal of a solute for high cut-off membrane depends on trans membrane pressure, which is conditioned by the rate of substitution, ultrafiltration, and dialysate. In order to achieve an acceptable balance between high cytokine and low albumin clearances, based on our former in vitro research result [<xref ref-type="bibr" rid="CR11">11</xref>], we designed optimal combination of replacement, ultrafiltration, and dialysate as PDF protocol description. Although lessening a little bit inflammation factor clearance, it ensured enough cytokine removal and minimum albumin lost.</p><p>In inflammation, overproduction of TNF-&#x003b1; is pivotal in the induction of inflammatory genes, cell death, and in the recruitment and activation of immune cells [<xref ref-type="bibr" rid="CR32">32</xref>]. In addition, it has been demonstrated that TNF-&#x003b1; plays a role in the control of epithelial permeability [<xref ref-type="bibr" rid="CR33">33</xref>&#x02013;<xref ref-type="bibr" rid="CR35">35</xref>]. Moreover, TNF-&#x003b1; at higher concentrations leads to downregulation of ZO-1 protein expression and disturbance in junction localization of ZO-1 protein and functional opening of TJ barrier [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. HMGB1, a potent late proinflammatory mediator in sepsis, also increased permeability of cultured epithelial monolayers in vitro and murine ileal mucosa in vivo [<xref ref-type="bibr" rid="CR4">4</xref>]. Furthermore, a serious mechanism researches reveal inhibiting gut epithelial apoptosis by overexpression of Bcl-2 was associated with a survival advantage in pseudomonas pneumonia-induced sepsis. This result suggested that intestinal epithelial apoptosis played a role in sepsis-related mortality [<xref ref-type="bibr" rid="CR37">37</xref>]. And Dr. Julian&#x02019;s findings indicated that intestinal epithelium was more susceptible to mitochondrial damage and dysfunction than the lung epithelium in the context of sepsis [<xref ref-type="bibr" rid="CR5">5</xref>]. Sepsis-induced inflammatory cells infiltration accompanied with cytokine releasing, epithelial apoptosis, and mitochondria dysfunction all involved in injury of gut tight junction [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. Therefore, intestinal failure is common in patients with septic shock, with dysfunction of the gut often manifesting as both a cause and consequence of their critical illness [<xref ref-type="bibr" rid="CR40">40</xref>].</p><p>Actually, CLP resulted in an increase of TNF-&#x003b1; and HMGB1 level, a marked appearance of dark brown apoptotic lymphocyte cells, and a significant disruption of immunosignal for ZO-1 and occludin along the epithelium. It is very gratifying to see that PDF effectively attenuated the TNF-&#x003b1; and HMGB1 levels in serum (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) and also improved apoptosis of lymphocyte and sepsis-related gut barrier injury.</p></sec><sec id="Sec18"><title>Conclusions</title><p>PDF can effectively eliminate more large pivotal inflammatory mediators of TNF&#x003b1; and HMGB1 and improve the sepsis-related gut barrier dysfunction and apoptosis of lymphocyte, and meanwhile, it benefits the circulation function and prolong the survival time. In the future, large multicenter randomized controlled trials will further appraise the power of PDF therapies to reduce mortality or organ failure, rather than only concerning on cytokine clearance or transient improvement in physiologic variables.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AKI</term><def><p>Acute kidney injury</p></def></def-item><def-item><term>CLP</term><def><p>Cecal ligation and puncture</p></def></def-item><def-item><term>CO</term><def><p>Cardiac output</p></def></def-item><def-item><term>Con.</term><def><p>Control</p></def></def-item><def-item><term>ELISA</term><def><p>Enzyme-linked immunosorbent assay</p></def></def-item><def-item><term>HCO</term><def><p>High cut-off</p></def></def-item><def-item><term>HMGB1</term><def><p>High-mobility group protein 1</p></def></def-item><def-item><term>HVHF</term><def><p>High-volume hemofiltration</p></def></def-item><def-item><term>LAC</term><def><p>Lactate</p></def></def-item><def-item><term>MAP</term><def><p>Mean arterial pressure</p></def></def-item><def-item><term>PaO<sub>2</sub></term><def><p>Partial pressure of blood oxygen</p></def></def-item><def-item><term>PAWP</term><def><p>Pulmonary artery wedge pressure</p></def></def-item><def-item><term>PDF</term><def><p>Plasmadiafiltration</p></def></def-item><def-item><term>Scr</term><def><p>Serum creatinine</p></def></def-item><def-item><term>SOFA</term><def><p>Sequential organ function assessment</p></def></def-item><def-item><term>TNF&#x003b1;</term><def><p>Tumor necrosis factor alpha</p></def></def-item><def-item><term>TUNEL</term><def><p>Terminal deoxynucleotidyl transferase mediated dUTP-biotin nick end labeling</p></def></def-item><def-item><term>WBC</term><def><p>White blood cell</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>The project was supported by &#x0201c;National Nature Science Foundation of China&#x0201d; (No.30770541; No. 81271731). Sincerely thank Prof Yutaka Eguchi (Critical and Intensive Care Medicine, Shiga University of Medical Science, Seta Tsukinowa, Ostsu, Shiga, Japan) for his continuous guidance during the whole study.</p><sec id="FPar1"><title>Funding</title><p>National Nature Science Foundation of China (No.30770541; No. 81271731).</p></sec><sec id="FPar2"><title>Authors&#x02019; contributions</title><p>MXL Li participated in the design of the study and performed the statistical analysis and drafted the manuscript. JFL participated in the design of the study and performed CLP model. JDL carried out the immunoassays. YZ performed laboratory measurements. DWK helped to draft the manuscript. JBX helped to operate with laparoscopy. PS also helped to operate with laparoscopy. WW administrated invasive hemodynamic measurement. JX conceived of the study, participated in its design and coordination and helped to draft the manuscript, and obtained funding. YG participated in the design of the study. CMH also participated in the design of the study. All authors read and approved the final manuscript.</p></sec><sec id="FPar3"><title>Competing interests</title><p>The authors declare that they have no competing of interests.</p></sec></ack><ref-list id="Bib1"><title>Reference</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Marshall</surname><given-names>JC</given-names></name><name><surname>Abraham</surname><given-names>E</given-names></name><name><surname>Angus</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>D</given-names></name><name><surname>Cohen</surname><given-names>J</given-names></name><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Ramsay</surname><given-names>G</given-names></name></person-group><article-title>2001 SCCM/ESICM/ACCP/ATs/SIS International Sepsis Definitions Conference</article-title><source>Intensive Care Med</source><year>2003</year><volume>29</volume><fpage>530</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1007/s00134-003-1662-x</pub-id><pub-id pub-id-type="pmid">12664219</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>CM</given-names></name></person-group><article-title>Increased gut permeability and bacterial translocation in Pseudomonas pneumonias induced sepsis</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><fpage>2573</fpage><lpage>2577</lpage><pub-id pub-id-type="doi">10.1097/00003246-200007000-00065</pub-id><pub-id pub-id-type="pmid">10921597</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Disruption of tight junctions during polymicrobial sepsis in vivo</article-title><source>J Pathol</source><year>2009</year><volume>218</volume><fpage>210</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1002/path.2525</pub-id><pub-id pub-id-type="pmid">19235836</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Miki</surname><given-names>K</given-names></name><name><surname>Oksala</surname><given-names>N</given-names></name><name><surname>Nakao</surname><given-names>A</given-names></name><name><surname>Lindgren</surname><given-names>L</given-names></name><name><surname>Killeen</surname><given-names>ME</given-names></name><name><surname>Mennander</surname><given-names>A</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Tenhunen</surname><given-names>J</given-names></name></person-group><article-title>Bile high-mobility group box1 contributes to gut barrier dysfunction in experimental endotoxemia</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2009</year><volume>297</volume><fpage>R362</fpage><lpage>r369</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.00184.2009</pub-id><pub-id pub-id-type="pmid">19494177</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julian</surname><given-names>MW</given-names></name><name><surname>Bao</surname><given-names>S</given-names></name><name><surname>Knoell</surname><given-names>DL</given-names></name><name><surname>Fahy</surname><given-names>RJ</given-names></name><name><surname>Shao</surname><given-names>G</given-names></name><name><surname>Crouser</surname><given-names>ED</given-names></name></person-group><article-title>Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than lung epithelium in the context of acute sepsis</article-title><source>In J Exp Path</source><year>2011</year><volume>92</volume><fpage>366</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2613.2011.00783.x</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>M</given-names></name><name><surname>Brealey</surname><given-names>D</given-names></name></person-group><article-title>Mitochondrial dysfunction in sepsis</article-title><source>Biochem Soc Symp</source><year>1999</year><volume>66</volume><fpage>149</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1042/bss0660149</pub-id><pub-id pub-id-type="pmid">10989665</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hotchkiss</surname><given-names>RS</given-names></name><name><surname>Nicholson</surname><given-names>DW</given-names></name></person-group><article-title>Apoptosis and caspases regulate death and inflammation in sepsis</article-title><source>Nat Rev Immunol</source><year>2006</year><volume>6</volume><fpage>813</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1038/nri1943</pub-id><pub-id pub-id-type="pmid">17039247</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Freitas</surname><given-names>I</given-names></name><name><surname>Fern&#x000e1;ndez-Somoza</surname><given-names>M</given-names></name><name><surname>Essenfeld-Sekler</surname><given-names>E</given-names></name><name><surname>Cardier</surname><given-names>JE</given-names></name></person-group><article-title>Serum levels of the apoptosis associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type I receptor and Fas/FasL in sepsis</article-title><source>Chest</source><year>2004</year><volume>125</volume><fpage>2238</fpage><lpage>2246</lpage><pub-id pub-id-type="doi">10.1378/chest.125.6.2238</pub-id><pub-id pub-id-type="pmid">15189947</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkataraman</surname><given-names>R</given-names></name><name><surname>Subramanian</surname><given-names>S</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name></person-group><article-title>Clinical review: extracorporeal blood purification in severe sepsis</article-title><source>Crit Care</source><year>2003</year><volume>7</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1186/cc1889</pub-id><pub-id pub-id-type="pmid">12720560</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Song</surname><given-names>M</given-names></name><name><surname>Venkataraman</surname><given-names>R</given-names></name></person-group><article-title>Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-&#x0043a;B DNA binding, and improves short-term survival in lethal endotoxemia</article-title><source>Crit Care Med</source><year>2004</year><volume>32</volume><fpage>801</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000114997.39857.69</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kuang</surname><given-names>D</given-names></name><name><surname>Gu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name></person-group><article-title>Efficacy of cytokine removal by plasmadiafiltration using a selective plasma separator: in vitro sepsis model</article-title><source>Ther Apher Dial</source><year>2011</year><volume>15</volume><fpage>98</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1111/j.1744-9987.2010.00850.x</pub-id><pub-id pub-id-type="pmid">21272259</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzon</surname><given-names>E</given-names></name><name><surname>Cuzzocrea</surname><given-names>S</given-names></name></person-group><article-title>Role of TNF-&#x003b1; in ileum tight junction alteration in mouse model of restraint stress</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2008</year><volume>294</volume><fpage>G1268</fpage><lpage>G1280</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00014.2008</pub-id><pub-id pub-id-type="pmid">18308862</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seymour</surname><given-names>CW</given-names></name><name><surname>Liu</surname><given-names>VX</given-names></name><name><surname>Iwashyna</surname><given-names>TJ</given-names></name><name><surname>Brunkhorst</surname><given-names>FM</given-names></name><name><surname>Rea</surname><given-names>TD</given-names></name><name><surname>Scherag</surname><given-names>A</given-names></name><name><surname>Rubenfeld</surname><given-names>G</given-names></name><name><surname>Kahn</surname><given-names>JM</given-names></name><name><surname>Shankar-Hari</surname><given-names>M</given-names></name><name><surname>Singer</surname><given-names>M</given-names></name><name><surname>Deutschman</surname><given-names>CS</given-names></name><name><surname>Escobar</surname><given-names>GJ</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name></person-group><article-title>Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)</article-title><source>JAMA</source><year>2016</year><volume>315</volume><fpage>762</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1001/jama.2016.0288</pub-id><pub-id pub-id-type="pmid">26903335</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejager</surname><given-names>L</given-names></name><name><surname>Pinheiro</surname><given-names>I</given-names></name><name><surname>Dejonckheere</surname><given-names>E</given-names></name><name><surname>Libert</surname><given-names>C</given-names></name></person-group><article-title>Cecal ligation and puncture:the gold standard model for polymicrobial sepsis?</article-title><source>Trends Microbiol</source><year>2011</year><volume>19</volume><fpage>198</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2011.01.001</pub-id><pub-id pub-id-type="pmid">21296575</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Singbartl</surname><given-names>K</given-names></name><name><surname>Simon</surname><given-names>P</given-names></name><name><surname>Rimmel&#x000e9;</surname><given-names>T</given-names></name><name><surname>Bishop</surname><given-names>J</given-names></name><name><surname>Clermont</surname><given-names>G</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name></person-group><article-title>Blood purification in sepsis: a new paradigm</article-title><source>Contrib Nephrol</source><year>2010</year><volume>165</volume><fpage>322</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1159/000313773</pub-id><pub-id pub-id-type="pmid">20427984</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Call</surname><given-names>DR</given-names></name><name><surname>Nemzek</surname><given-names>JA</given-names></name><name><surname>Ebong</surname><given-names>SJ</given-names></name><name><surname>Bolgos</surname><given-names>GL</given-names></name><name><surname>Newcomb</surname><given-names>DE</given-names></name><name><surname>Remick</surname><given-names>DG</given-names></name></person-group><article-title>Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment</article-title><source>Am J Pathol</source><year>2001</year><volume>158</volume><fpage>715</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64014-X</pub-id><pub-id pub-id-type="pmid">11159209</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimmel&#x000e9;</surname><given-names>T</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name></person-group><article-title>Clinical review: Blood purification for sepsis</article-title><source>Crit Care</source><year>2011</year><volume>15</volume><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1186/cc9411</pub-id><pub-id pub-id-type="pmid">21371356</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lins</surname><given-names>RL</given-names></name><name><surname>Elseviers</surname><given-names>MM</given-names></name><name><surname>Van der Niepen</surname><given-names>P</given-names></name><name><surname>Hoste</surname><given-names>E</given-names></name><name><surname>Malbrain</surname><given-names>ML</given-names></name><name><surname>Damas</surname><given-names>P</given-names></name><name><surname>Devriendt</surname><given-names>J</given-names></name></person-group><article-title>SHARF investigators: Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial</article-title><source>Nephrol Dial Transplant</source><year>2009</year><volume>24</volume><fpage>512</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfn560</pub-id><pub-id pub-id-type="pmid">18854418</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vinsonneau</surname><given-names>C</given-names></name><name><surname>Camus</surname><given-names>C</given-names></name><name><surname>Combes</surname><given-names>A</given-names></name><name><surname>Costa de Beauregard</surname><given-names>MA</given-names></name><name><surname>Klouche</surname><given-names>K</given-names></name><name><surname>Boulain</surname><given-names>T</given-names></name><name><surname>Pallot</surname><given-names>JL</given-names></name><name><surname>Chiche</surname><given-names>JD</given-names></name><name><surname>Taupin</surname><given-names>P</given-names></name><name><surname>Landais</surname><given-names>P</given-names></name><name><surname>Dhainaut</surname><given-names>JF</given-names></name></person-group><article-title>Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial</article-title><source>Lancet</source><year>2006</year><volume>368</volume><fpage>379</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(06)69111-3</pub-id><pub-id pub-id-type="pmid">16876666</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>R</given-names></name><name><surname>Shariff</surname><given-names>SZ</given-names></name><name><surname>Adhikari</surname><given-names>NK</given-names></name><name><surname>Bagshaw</surname><given-names>SM</given-names></name><name><surname>Burns</surname><given-names>KE</given-names></name><name><surname>Friedrich</surname><given-names>JO</given-names></name><name><surname>Garg</surname><given-names>AX</given-names></name><name><surname>Harel</surname><given-names>Z</given-names></name><name><surname>Kitchlu</surname><given-names>A</given-names></name><name><surname>Ray</surname><given-names>JG</given-names></name></person-group><article-title>The Association Between Renal Replacement Therapy Modality and Long-Term Outcomes Among Critically Ill Adults With Acute Kidney Injury: A Retrospective Cohort Study</article-title><source>Crit Care Med</source><year>2014</year><volume>42</volume><fpage>868</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000000042</pub-id><pub-id pub-id-type="pmid">24275513</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Cass</surname><given-names>A</given-names></name><name><surname>Cole</surname><given-names>L</given-names></name><name><surname>Finfer</surname><given-names>S</given-names></name><name><surname>Gallagher</surname><given-names>M</given-names></name><name><surname>Lo</surname><given-names>S</given-names></name><name><surname>McArthur</surname><given-names>C</given-names></name><name><surname>McGuinness</surname><given-names>S</given-names></name><name><surname>Myburgh</surname><given-names>J</given-names></name><name><surname>Norton</surname><given-names>R</given-names></name><name><surname>Scheinkestel</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>S</given-names></name></person-group><article-title>Intensity of continuous renal-replacement therapy in critically ill patients</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><fpage>1627</fpage><lpage>1638</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0902413</pub-id><pub-id pub-id-type="pmid">19846848</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palevsky</surname><given-names>PM</given-names></name><name><surname>Zhang</surname><given-names>JH</given-names></name><name><surname>O'Connor</surname><given-names>TZ</given-names></name><name><surname>Chertow</surname><given-names>GM</given-names></name><name><surname>Crowley</surname><given-names>ST</given-names></name><name><surname>Choudhury</surname><given-names>D</given-names></name><name><surname>Finkel</surname><given-names>K</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Paganini</surname><given-names>E</given-names></name><name><surname>Schein</surname><given-names>RM</given-names></name><name><surname>Smith</surname><given-names>MW</given-names></name><name><surname>Swanson</surname><given-names>KM</given-names></name><name><surname>Thompson</surname><given-names>BT</given-names></name><name><surname>Vijayan</surname><given-names>A</given-names></name><name><surname>Watnick</surname><given-names>S</given-names></name><name><surname>Star</surname><given-names>RA</given-names></name><name><surname>Peduzzi</surname><given-names>P</given-names></name></person-group><article-title>Intensity of renal support in critically ill patients with acute kidney injury</article-title><source>N Engl J Med</source><year>2008</year><volume>359</volume><fpage>7</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0802639</pub-id><pub-id pub-id-type="pmid">18492867</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vesconi</surname><given-names>S</given-names></name><name><surname>Cruz</surname><given-names>DN</given-names></name><name><surname>Fumagalli</surname><given-names>R</given-names></name><name><surname>Kindgen-Milles</surname><given-names>D</given-names></name><name><surname>Monti</surname><given-names>G</given-names></name><name><surname>Marinho</surname><given-names>A</given-names></name><name><surname>Mariano</surname><given-names>F</given-names></name><name><surname>Formica</surname><given-names>M</given-names></name><name><surname>Marchesi</surname><given-names>M</given-names></name><name><surname>Ren&#x000e9;</surname><given-names>R</given-names></name><name><surname>Livigni</surname><given-names>S</given-names></name><name><surname>Ronco</surname><given-names>C</given-names></name></person-group><article-title>Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury</article-title><source>Crit Care</source><year>2009</year><volume>13</volume><fpage>R57</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1186/cc7784</pub-id><pub-id pub-id-type="pmid">19368724</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joannes-Boyau</surname><given-names>O</given-names></name><name><surname>Honor&#x000e9;</surname><given-names>PM</given-names></name><name><surname>Perez</surname><given-names>P</given-names></name><name><surname>Bagshaw</surname><given-names>SM</given-names></name><name><surname>Grand</surname><given-names>H</given-names></name><name><surname>Canivet</surname><given-names>JL</given-names></name><name><surname>Dewitte</surname><given-names>A</given-names></name><name><surname>Flamens</surname><given-names>C</given-names></name><name><surname>Pujol</surname><given-names>W</given-names></name><name><surname>Grandoulier</surname><given-names>AS</given-names></name><name><surname>Fleureau</surname><given-names>C</given-names></name><name><surname>Jacobs</surname><given-names>R</given-names></name><name><surname>Broux</surname><given-names>C</given-names></name><name><surname>Floch</surname><given-names>H</given-names></name><name><surname>Branchard</surname><given-names>O</given-names></name><name><surname>Franck</surname><given-names>S</given-names></name><name><surname>Roz&#x000e9;</surname><given-names>H</given-names></name><name><surname>Collin</surname><given-names>V</given-names></name><name><surname>Boer</surname><given-names>W</given-names></name><name><surname>Calderon</surname><given-names>J</given-names></name><name><surname>Gauche</surname><given-names>B</given-names></name><name><surname>Spapen</surname><given-names>HD</given-names></name><name><surname>Janvier</surname><given-names>G</given-names></name><name><surname>Ouattara</surname><given-names>A</given-names></name></person-group><article-title>High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial</article-title><source>Intensive Care Med</source><year>2013</year><volume>39</volume><fpage>1535</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.1007/s00134-013-2967-z</pub-id><pub-id pub-id-type="pmid">23740278</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>H</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Chao</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study</article-title><source>Crit Care</source><year>2014</year><volume>18</volume><fpage>R70</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1186/cc13827</pub-id><pub-id pub-id-type="pmid">24716613</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwenger</surname><given-names>V</given-names></name><name><surname>Weigand</surname><given-names>MA</given-names></name><name><surname>Hoffmann</surname><given-names>O</given-names></name><name><surname>Dikow</surname><given-names>R</given-names></name><name><surname>Kihm</surname><given-names>LP</given-names></name><name><surname>Seckinger</surname><given-names>J</given-names></name><name><surname>Miftari</surname><given-names>N</given-names></name><name><surname>Schaier</surname><given-names>M</given-names></name><name><surname>Hofer</surname><given-names>S</given-names></name><name><surname>Haar</surname><given-names>C</given-names></name><name><surname>Nawroth</surname><given-names>PP</given-names></name><name><surname>Zeier</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Morath</surname><given-names>C</given-names></name></person-group><article-title>Sustained low efficiency dialysis using a single- pass batch system in acute kidney injury - a randomized interventional trial: the Renal Replacement Therapy Study in Intensive Care Unit Patients</article-title><source>Crit Care</source><year>2012</year><volume>16</volume><fpage>R140</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1186/cc11445</pub-id><pub-id pub-id-type="pmid">22839577</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kielstein</surname><given-names>JT</given-names></name><name><surname>Kretschmer</surname><given-names>U</given-names></name><name><surname>Ernst</surname><given-names>T</given-names></name><name><surname>Hafer</surname><given-names>C</given-names></name><name><surname>Bahr</surname><given-names>MJ</given-names></name><name><surname>Haller</surname><given-names>H</given-names></name><name><surname>Fliser</surname><given-names>D</given-names></name></person-group><article-title>Efficacy and Cardiovascular Tolerability of Extended Dialysis in Critically Ill Patients: A Randomized Controlled Study</article-title><source>Am J Kidney Dis</source><year>2004</year><volume>43</volume><fpage>342</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1053/j.ajkd.2003.10.021</pub-id><pub-id pub-id-type="pmid">14750100</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honor&#x000e9;</surname><given-names>PM</given-names></name><name><surname>Jacobs</surname><given-names>R</given-names></name><name><surname>Joannes-Boyau</surname><given-names>O</given-names></name><name><surname>De Waele</surname><given-names>E</given-names></name><name><surname>Van Gorp</surname><given-names>V</given-names></name><name><surname>Boer</surname><given-names>W</given-names></name><name><surname>Spapen</surname><given-names>HD</given-names></name></person-group><article-title>Con: Dialy- and continuous renal replacement (CRRT) trauma during renal replacement therapy: still under-recognized but on the way to better diagnostic understanding and prevention</article-title><source>Nephrol Dial Transplant</source><year>2013</year><volume>28</volume><fpage>2723</fpage><lpage>2728</lpage><pub-id pub-id-type="doi">10.1093/ndt/gft086</pub-id><pub-id pub-id-type="pmid">24169609</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>PA</given-names></name><name><surname>Weger</surname><given-names>GW</given-names></name><name><surname>Pryor</surname><given-names>RW</given-names></name><name><surname>Matson</surname><given-names>JR</given-names></name></person-group><article-title>Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine</article-title><source>Crit Care Med</source><year>1998</year><volume>26</volume><fpage>730</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1097/00003246-199804000-00024</pub-id><pub-id pub-id-type="pmid">9559612</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgera</surname><given-names>S</given-names></name><name><surname>Haase</surname><given-names>M</given-names></name><name><surname>Kuss</surname><given-names>T</given-names></name><name><surname>Vargas-Hein</surname><given-names>O</given-names></name><name><surname>Zuckermann-Becker</surname><given-names>H</given-names></name><name><surname>Melzer</surname><given-names>C</given-names></name><name><surname>Krieg</surname><given-names>H</given-names></name><name><surname>Wegner</surname><given-names>B</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Neumayer</surname><given-names>HH</given-names></name></person-group><article-title>Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><fpage>2099</fpage><lpage>2104</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000229147.50592.F9</pub-id><pub-id pub-id-type="pmid">16763508</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgera</surname><given-names>S</given-names></name><name><surname>Haase</surname><given-names>M</given-names></name><name><surname>Rockt&#x000e4;schel</surname><given-names>J</given-names></name><name><surname>B&#x000f6;hler</surname><given-names>T</given-names></name><name><surname>von Heymann</surname><given-names>C</given-names></name><name><surname>Vargas-Hein</surname><given-names>O</given-names></name><name><surname>Krausch</surname><given-names>D</given-names></name><name><surname>Zuckermann-Becker</surname><given-names>H</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>JM</given-names></name><name><surname>Kox</surname><given-names>WJ</given-names></name><name><surname>Neumayer</surname><given-names>HH</given-names></name></person-group><article-title>High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure</article-title><source>Nephrol Dial Transplant</source><year>2003</year><volume>18</volume><fpage>2570</fpage><lpage>2576</lpage><pub-id pub-id-type="doi">10.1093/ndt/gfg435</pub-id><pub-id pub-id-type="pmid">14605279</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>HM</given-names></name><name><surname>Pervaiz</surname><given-names>S</given-names></name></person-group><article-title>TNF receptor superfamily-induced cell death: redox-dependent execution</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><fpage>1589</fpage><lpage>1598</lpage><pub-id pub-id-type="doi">10.1096/fj.05-5603rev</pub-id><pub-id pub-id-type="pmid">16873882</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruewer</surname><given-names>M</given-names></name><name><surname>Luegering</surname><given-names>A</given-names></name><name><surname>Kucharzik</surname><given-names>T</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name><name><surname>Madara</surname><given-names>JL</given-names></name><name><surname>Hopkins</surname><given-names>AM</given-names></name><name><surname>Nusrat</surname><given-names>A</given-names></name></person-group><article-title>Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms</article-title><source>J Immunol</source><year>2003</year><volume>171</volume><fpage>6164</fpage><lpage>6172</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.11.6164</pub-id><pub-id pub-id-type="pmid">14634132</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Fink</surname><given-names>MP</given-names></name><name><surname>Uchiyama</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Delude</surname><given-names>RL</given-names></name></person-group><article-title>Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2004</year><volume>286</volume><fpage>L259</fpage><lpage>L267</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00187.2003</pub-id><pub-id pub-id-type="pmid">12896879</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>TY</given-names></name><name><surname>Iwamoto</surname><given-names>GK</given-names></name><name><surname>Hoa</surname><given-names>NT</given-names></name><name><surname>Akotia</surname><given-names>V</given-names></name><name><surname>Pedram</surname><given-names>A</given-names></name><name><surname>Boivin</surname><given-names>MA</given-names></name><name><surname>Said</surname><given-names>HM</given-names></name></person-group><article-title>TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kB activation</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2004</year><volume>286</volume><fpage>G367</fpage><lpage>G376</lpage><pub-id pub-id-type="doi">10.1152/ajpgi.00173.2003</pub-id><pub-id pub-id-type="pmid">14766535</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyne</surname><given-names>CB</given-names></name><name><surname>Vanhook</surname><given-names>MK</given-names></name><name><surname>Gambling</surname><given-names>TM</given-names></name><name><surname>Carson</surname><given-names>JL</given-names></name><name><surname>Boucher</surname><given-names>RC</given-names></name><name><surname>Johnson</surname><given-names>LG</given-names></name></person-group><article-title>Regulation of airway tight junctions by proinflammatory cytokines</article-title><source>Mol Biol Cell</source><year>2002</year><volume>13</volume><fpage>3218</fpage><lpage>3234</lpage><pub-id pub-id-type="doi">10.1091/mbc.E02-03-0134</pub-id><pub-id pub-id-type="pmid">12221127</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coopersmith</surname><given-names>CM</given-names></name><name><surname>Stromberg</surname><given-names>PE</given-names></name><name><surname>Dunne</surname><given-names>WM</given-names></name><name><surname>Davis</surname><given-names>CG</given-names></name><name><surname>Amiot</surname><given-names>DM</given-names><suffix>2nd</suffix></name><name><surname>Buchman</surname><given-names>TG</given-names></name><name><surname>Karl</surname><given-names>IE</given-names></name><name><surname>Hotchkiss</surname><given-names>RS</given-names></name></person-group><article-title>Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis</article-title><source>JAMA</source><year>2002</year><volume>287</volume><fpage>1716</fpage><lpage>1721</lpage><pub-id pub-id-type="doi">10.1001/jama.287.13.1716</pub-id><pub-id pub-id-type="pmid">11926897</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Al-Sadi</surname><given-names>R</given-names></name><name><surname>Said</surname><given-names>HM</given-names></name><name><surname>Ma</surname><given-names>TY</given-names></name></person-group><article-title>Lipopolysaccharide Causes an Increase in Intestinal Tight Junction Permeability in Vitro and in Vivo by Inducing Enterocyte Membrane Expression and Localization of TLR-4 and CD14</article-title><source>Am J Pathol</source><year>2013</year><volume>182</volume><fpage>375</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2012.10.014</pub-id><pub-id pub-id-type="pmid">23201091</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnier</surname><given-names>DI</given-names></name><name><surname>Bailey</surname><given-names>SR</given-names></name><name><surname>Schuster</surname><given-names>RM</given-names></name><name><surname>Gangidine</surname><given-names>MM</given-names></name><name><surname>Lentsch</surname><given-names>AB</given-names></name><name><surname>Pritts</surname><given-names>TA</given-names></name></person-group><article-title>Proinflammatory chemokines in the intestinal lumen contribute to intestinal dysfunction during endotoxemia</article-title><source>Shock</source><year>2012</year><volume>37</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1097/SHK.0b013e31823cbff1</pub-id><pub-id pub-id-type="pmid">22089201</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>MP</given-names></name></person-group><article-title>Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness</article-title><source>Curr Opin Crit Care</source><year>2003</year><volume>9</volume><fpage>143</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1097/00075198-200304000-00011</pub-id><pub-id pub-id-type="pmid">12657978</pub-id></element-citation></ref></ref-list></back></article>